133 related articles for article (PubMed ID: 18624851)
1. Successful treatment of linear Darier's disease with topical adapalene.
Casals M; Campoy A; Aspiolea F; Carrasco MA; Camps A
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):237-8. PubMed ID: 18624851
[No Abstract] [Full Text] [Related]
2. Successful treatment of Darier's disease with adapalene gel.
Abe M; Inoue C; Yokoyama Y; Ishikawa O
Pediatr Dermatol; 2011; 28(2):197-8. PubMed ID: 20403120
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of localized Darier's disease with adapalene 0.1% gel.
English JC; Browne J; Halbach DP
Cutis; 1999 Apr; 63(4):227-30. PubMed ID: 10228752
[TBL] [Abstract][Full Text] [Related]
4. Acral Darier's disease successfully treated with adapalene.
Cianchini G; Colonna L; Camaioni D; Annessi G; Puddu P
Acta Derm Venereol; 2001; 81(1):57-8. PubMed ID: 11411920
[No Abstract] [Full Text] [Related]
5. Management of Darier's disease.
Burge S
Clin Exp Dermatol; 1999 Mar; 24(2):53-6. PubMed ID: 10233651
[TBL] [Abstract][Full Text] [Related]
6. Tazarotene gel for Darier's disease.
Burkhart CG; Burkhart CN
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):1001-2. PubMed ID: 9632016
[No Abstract] [Full Text] [Related]
7. Pityriasis amiantacea as the sole manifestation of Darier's disease.
Hussain W; Coulson IH; Salman WD
Clin Exp Dermatol; 2009 Jun; 34(4):554-6. PubMed ID: 19522991
[No Abstract] [Full Text] [Related]
8. Clinical improvement in Darier's disease with photodynamic therapy.
Avery HL; Hughes BR; Coley C; Cooper HL
Australas J Dermatol; 2010 Feb; 51(1):32-5. PubMed ID: 20148839
[TBL] [Abstract][Full Text] [Related]
9. Vulval Darier's disease treated successfully with ciclosporin.
Stewart LC; Yell J
J Obstet Gynaecol; 2008 Jan; 28(1):108-9. PubMed ID: 18259917
[No Abstract] [Full Text] [Related]
10. Successful treatment of Darier's disease with topical pimecrolimus.
Pérez-Carmona L; Fleta-Asín B; Moreno-García-Del-Real C; Jaén-Olasolo P
Eur J Dermatol; 2011; 21(2):301-2. PubMed ID: 21489907
[No Abstract] [Full Text] [Related]
11. Successful treatment with oral alitretinoin in women of childbearing potential with Darier's disease.
Zamiri M; Munro CS
Br J Dermatol; 2013 Sep; 169(3):709-10. PubMed ID: 23551220
[No Abstract] [Full Text] [Related]
12. Unilateral Darier's disease associated with migraine headache responsive to isotretinoin.
Rotunda AM; Cotliar J; Haley JC; Craft N
J Am Acad Dermatol; 2005 Jan; 52(1):175-6. PubMed ID: 15627112
[No Abstract] [Full Text] [Related]
13. [Efficacy and risks of topical 5-fluorouracil in Darier's disease].
Le Bidre E; Delage M; Celerier P; De Muret A; Lorette G
Ann Dermatol Venereol; 2010; 137(6-7):455-9. PubMed ID: 20620575
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of linear Darier's disease with topical retinoids: case report and review of the literature.
Dogan S; Karaduman A; Erkin G; Gokoz O
Acta Dermatovenerol Croat; 2011; 19(3):206-9. PubMed ID: 21933650
[No Abstract] [Full Text] [Related]
15. Sporadic late-onset Darier's disease.
Chew CY; Nguyen RA
Australas J Dermatol; 2020 Nov; 61(4):e436-e438. PubMed ID: 32578198
[No Abstract] [Full Text] [Related]
16. [Localized Darier's disease. Topical treatment with retinoic acid].
Zamora Martín E; Martín Moreno L; de Castro Torres A; Barat Cascante A
Med Cutan Ibero Lat Am; 1988; 16(2):161-3. PubMed ID: 3050334
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Thiboutot D; Arsonnaud S; Soto P
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of Darier disease with topical 5-fluorouracil.
Yoon TY; Kim JW; Kim MK
Br J Dermatol; 2006 Jun; 154(6):1210-2. PubMed ID: 16704663
[No Abstract] [Full Text] [Related]
19. [Use of aerosol preparations in external therapy of patients with eczema].
Somov BA; Ivanov VV
Vestn Dermatol Venerol; 1974 Oct; 0(10):52-4. PubMed ID: 4432617
[No Abstract] [Full Text] [Related]
20. Linear Darier's disease successfully treated with 0.1% tazarotene gel "short-contact" therapy.
Brazzelli V; Prestinari F; Barbagallo T; Vassallo C; Agozzino M; Borroni G
Eur J Dermatol; 2006; 16(1):59-61. PubMed ID: 16436344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
